NCT06362824 · Kaiser Permanente
Promoting Physical Activity in Older Hispanic/Latino(a) Adults
What this study is about
In this randomly assigned controlled trial, study staff will randomize 130 Hispanic/Latino adults without dementia and over age 55 from Southern California and from Kaiser Permanente Washington (State) to either the culturally adapted De Pie physical activity intervention or an active comparison program focusing on general brain health topics.
View original scientific description
In this randomized controlled trial, study staff will randomize 130 Hispanic/Latino adults without dementia and over age 55 from Southern California and from Kaiser Permanente Washington (State) to either the culturally adapted De Pie physical activity intervention or an active comparison program focusing on general brain health topics. The purpose of this study is to determine if 12 weeks of the culturally adapted and fully remote De Pie y a Movernos intervention improves self-efficacy, habit strength, social support, and enjoyment for physical activity (PA), thus promoting adherence to moderate-intensity physical activity (MIPA) guidelines (150 minutes/week).
Interventions
BEHAVIORAL
De Pie Intervention
Participants are guided by a health coach trained in motivational interviewing through 6 biweekly phone sessions. Each session involves reviewing goals and problem-solving barriers from the prior 2 weeks experience; covering a topic related to Step 1 goals (or Step 2 goals if they pass the safety assessment) such as how to enjoy movement, social support, and using your surroundings; and setting goals and an action plan for the following two weeks.
OTHER
Active Comparison Group: Healthy Actions And Lifestyles To Avoid Dementia (HALT-AD)
Those in the active comparison program will receive no additional health coaching sessions. They will work through the HALT-AD content at their own pace, setting goals in the online platform as they go.
Primary outcome measures
Change in Moderate Intensity Physical Activity (MIPA) minutes/day
Time frame: Baseline to 12 weeks
Time (minutes) spent being physically active during waking hours will be measured objectively by the ActiGraph worn for one week at Baseline and again after 12 weeks
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- be 55-89 and self-identify as Hispanic/Latino(a)
- able to participate for up to 20 weeks in the study
- willing to be randomized to the intervention or active comparison program
- willing to follow study procedures depending on program assignment
- available M-F for study phone calls between 8am-5pm
- able to walk one block unassisted,
- able to speak and can read Spanish or English,
- have a smartphone (85% of the Hispanic/Latino(a) population has a smartphone)
- willing to wear an ActiGraph for up to 2 weeks, twice during the course of the study
- willing to complete study questionnaires via weblink, paper, or phone call
- have an email address and be willing to share it with the team
- have a US mailing address where they receive mail regularly (confirmed in pre-screen)
Exclusion criteria
- are as follows:
- score less than or equal to 4 on the Six-Item Screener (Callahan et al., 2002)
- unable to hear phone conversation, even with a hearing aid
- planned surgeries or travel that would interfere with participation
- had a fall in the last year that resulted in hospitalization
- had a cancer diagnosis that requires treatment in the past year (other than skin cancer)
- had a diagnosis of heart attack or irregular heart beat (arrythmia) in the past year
- been advised recently by their doctor to avoid physical activity
- does not want to share cognitive health information collected during the study with researchers at UCSD
- unwilling to share their email address
- unwilling to obtain an email address if they do not already have one
- currently participating in another institution's physical activity study
Where
- San Diego, California
- Seattle, Washington
Collaborators
University of California, San Diego
Related conditions & keywords
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced Apr 8, 2026 · Source of record for eligibility and locations